Matthew Anson , Alex E. Henney , Harry Edwards , Gema H. Ibarburu , Ify Mordi , Shabbar Jaffar , Anupam Garrib , Gregory Y.H. Lip , Duolao Wang , Katarzyna Nabrdalik , Bruce A. Perkins , Daniel J. Cuthbertson , Uazman Alam
{"title":"2型糖尿病和大血管和微血管并发症发病率的迅速增加对年轻年龄组的影响尤为严重:来自国际联合数据库的十年证据","authors":"Matthew Anson , Alex E. Henney , Harry Edwards , Gema H. Ibarburu , Ify Mordi , Shabbar Jaffar , Anupam Garrib , Gregory Y.H. Lip , Duolao Wang , Katarzyna Nabrdalik , Bruce A. Perkins , Daniel J. Cuthbertson , Uazman Alam","doi":"10.1016/j.diabres.2025.112431","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>To characterise recent trends in incidence and prevalence of type 2 diabetes (T2D) associated complications, and their relative impact across the lifespan.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cohort study using the TriNetX global federated database. Incidence and prevalence of T2D and associated complications: ischaemic heart disease (IHD), heart failure, cerebral infarction, neuropathy, nephropathy, and retinopathy were assessed between 2012 and 2023. Incidence odds ratios (IOR) were calculated by age group.</div></div><div><h3>Results</h3><div>7,918,666 individuals had T2D. The IOR (95 % CI), comparing individuals aged ≥ 85 years to < 35 years decreased for all complications from 2012 to 2023: <strong>IHD</strong> [IOR 6.82, (6.40, 7.26) to IOR 2.27 (2.17, 2.38)], <strong>heart failure</strong> [IOR 5.38, (5.03, 5.75) to IOR 1.80 (1.72, 1.89)], <strong>cerebral infarction</strong> [IOR 3.06, (2.76, 3.40) to IOR 1.45 (1.34, 1.57)], <strong>neuropathy</strong> [IOR 0.84, (0.74, 0.95) to IOR 0.47 (0.44, 0.49)], <strong>nephropathy</strong> [IOR 1.14, (1.03, 1.27) to IOR 0.90 (0.87, 0.94)] and <strong>retinopathy</strong> [IOR 0.56, (0.50, 0.63) to IOR 0.27 (0.25, 0.29)].</div></div><div><h3>Conclusions</h3><div>Rising rates of T2D associated complications in younger adults signal an emerging epidemic of early-onset comorbidity with substantial lifetime burden. These findings emphasise the urgent need for earlier detection, aggressive risk factor management, and targeted prevention strategies in younger populations.</div></div>","PeriodicalId":11249,"journal":{"name":"Diabetes research and clinical practice","volume":"228 ","pages":"Article 112431"},"PeriodicalIF":7.4000,"publicationDate":"2025-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The rapidly increasing incidence of type 2 diabetes and macrovascular and microvascular complications disproportionately affects younger age groups: A decade of evidence from an international federated database\",\"authors\":\"Matthew Anson , Alex E. Henney , Harry Edwards , Gema H. Ibarburu , Ify Mordi , Shabbar Jaffar , Anupam Garrib , Gregory Y.H. Lip , Duolao Wang , Katarzyna Nabrdalik , Bruce A. Perkins , Daniel J. Cuthbertson , Uazman Alam\",\"doi\":\"10.1016/j.diabres.2025.112431\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Aims</h3><div>To characterise recent trends in incidence and prevalence of type 2 diabetes (T2D) associated complications, and their relative impact across the lifespan.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cohort study using the TriNetX global federated database. Incidence and prevalence of T2D and associated complications: ischaemic heart disease (IHD), heart failure, cerebral infarction, neuropathy, nephropathy, and retinopathy were assessed between 2012 and 2023. Incidence odds ratios (IOR) were calculated by age group.</div></div><div><h3>Results</h3><div>7,918,666 individuals had T2D. The IOR (95 % CI), comparing individuals aged ≥ 85 years to < 35 years decreased for all complications from 2012 to 2023: <strong>IHD</strong> [IOR 6.82, (6.40, 7.26) to IOR 2.27 (2.17, 2.38)], <strong>heart failure</strong> [IOR 5.38, (5.03, 5.75) to IOR 1.80 (1.72, 1.89)], <strong>cerebral infarction</strong> [IOR 3.06, (2.76, 3.40) to IOR 1.45 (1.34, 1.57)], <strong>neuropathy</strong> [IOR 0.84, (0.74, 0.95) to IOR 0.47 (0.44, 0.49)], <strong>nephropathy</strong> [IOR 1.14, (1.03, 1.27) to IOR 0.90 (0.87, 0.94)] and <strong>retinopathy</strong> [IOR 0.56, (0.50, 0.63) to IOR 0.27 (0.25, 0.29)].</div></div><div><h3>Conclusions</h3><div>Rising rates of T2D associated complications in younger adults signal an emerging epidemic of early-onset comorbidity with substantial lifetime burden. These findings emphasise the urgent need for earlier detection, aggressive risk factor management, and targeted prevention strategies in younger populations.</div></div>\",\"PeriodicalId\":11249,\"journal\":{\"name\":\"Diabetes research and clinical practice\",\"volume\":\"228 \",\"pages\":\"Article 112431\"},\"PeriodicalIF\":7.4000,\"publicationDate\":\"2025-08-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes research and clinical practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0168822725004450\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes research and clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168822725004450","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
The rapidly increasing incidence of type 2 diabetes and macrovascular and microvascular complications disproportionately affects younger age groups: A decade of evidence from an international federated database
Aims
To characterise recent trends in incidence and prevalence of type 2 diabetes (T2D) associated complications, and their relative impact across the lifespan.
Methods
We conducted a retrospective cohort study using the TriNetX global federated database. Incidence and prevalence of T2D and associated complications: ischaemic heart disease (IHD), heart failure, cerebral infarction, neuropathy, nephropathy, and retinopathy were assessed between 2012 and 2023. Incidence odds ratios (IOR) were calculated by age group.
Results
7,918,666 individuals had T2D. The IOR (95 % CI), comparing individuals aged ≥ 85 years to < 35 years decreased for all complications from 2012 to 2023: IHD [IOR 6.82, (6.40, 7.26) to IOR 2.27 (2.17, 2.38)], heart failure [IOR 5.38, (5.03, 5.75) to IOR 1.80 (1.72, 1.89)], cerebral infarction [IOR 3.06, (2.76, 3.40) to IOR 1.45 (1.34, 1.57)], neuropathy [IOR 0.84, (0.74, 0.95) to IOR 0.47 (0.44, 0.49)], nephropathy [IOR 1.14, (1.03, 1.27) to IOR 0.90 (0.87, 0.94)] and retinopathy [IOR 0.56, (0.50, 0.63) to IOR 0.27 (0.25, 0.29)].
Conclusions
Rising rates of T2D associated complications in younger adults signal an emerging epidemic of early-onset comorbidity with substantial lifetime burden. These findings emphasise the urgent need for earlier detection, aggressive risk factor management, and targeted prevention strategies in younger populations.
期刊介绍:
Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.